vimarsana.com

Page 31 - Using Artificial Intelligence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FTC Warning: Artificial Intelligence Bias Potential for Enforcement Liability

FTC Issues New Guidance, Warning That Bias in Artificial Intelligence Could Create Potential Liability for Enforcement Actions Saturday, April 24, 2021 On Monday, 19 April 2021, a Federal Trade Commission (FTC) blog post warned companies to ensure that their artificial intelligence (AI) does not reflect racial or gender bias, and it indicated that failure to do so may result in “deception, discrimination and an FTC law enforcement action.” 1 Although this is not the first time the FTC has addressed the issue of bias in AI, the agency has now made it clear that if businesses fail to hold themselves accountable for all actions both human and AI they should “be ready for the FTC to do it for [them].”

70 Stellar Speakers Share their Thoughts on Borderless Work at the HREA Work Festival 2021

Partner Share this article Global thought leaders and professionals from across different sectors in Africa gathered at the Landmark Event Centre, Lagos, and on Airmeet, the HREA event’s virtual platform to share their insights on innovations shaping the world of work, with particular focus on ‘Borderless Work’ The 2-day HREA Work Festival 2021 which held from April 14 to 15 had leaders in technology, finance, healthcare, human resource, governance and social enterprise, among others, lead conversations around new trends in the world of work as can be witnessed in the different sectors of the economy globally.  The event attracted over 5,000 participants from across industries that make up today’s global workforce, many seeking to build profitable connections and great businesses under a serene learning and exhibition environment.

Enzolytics, Inc : Enzolytics Reports Progress On Its Multiple Therapeutics Platforms and Initiatives

Enzolytics, Inc.: Enzolytics Reports Progress On Its Multiple Therapeutics Platforms and Initiatives COLLEGE STATION, TX / ACCESSWIRE / April 19, 2021 / Enzolytics, Inc. (OTC Markets ENZC or the Company ). We continue to make great strides in the application of our multiple platforms for production of therapeutics for treating infectious diseases. Our future success will follow as we meet our goals to bring these therapeutics to market with new developments made possible by our extensive platform for producing new and effective therapies. We acknowledge our partners Genscript (https://www.genscript.com), STC Biologics (https://stcbiologics.com) and California National Primate Research Center (University of Southern California) for their continued support in our research and development efforts. We are also grateful for the overwhelming support from world-renowned scientists and continue to expand our team of advisors to build a strong company based on research and development.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.